Nabilone & Marijuana Addiction

University of British Columbia

Status and phase: Completed; Phase 3; Phase 2

Conditions: Marijuana Smoking

Treatments: Drug: Cesemat

Study type: Interventional

Funder types: Other

Identifiers

NCT01025700

H08-01999

Details and patient eligibility

About

Safety of Nabilone in reducing marijuana craving

Full description

Randomized double blind trial into the safety and efficacy of Cesemat for the treatment of marijuana use

Enrollment: 35 estimated patients

Sex: All

Ages: 19 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• 19 years or older
• History of marijuana use

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

35 participants in 2 patient groups

Cesemat

Experimental group

Treatment:

Drug: Cesemat

Placebo

No Intervention group